Our latest news, insights & events
Join us for a one of a kind conference about enhancing, expanding and maintaining your worldwide trademark and domain name

Globalising Your Branding Strategy | Herzog Fox & Neeman’s Intellectual Property Event | 12.3.18
Herzog Fox & Neeman’s tax partners, Meir Linzen and Guy Katz, co-authored the Israel Law and Practice chapter, providing easily

Chambers Tax Guide 2018 | Law & Practice Chapter by Meir Linzen and Guy Katz
Teva Pharmaceuticals Industries Limited announced on March 7th 2018, the pricing of an offering of $4.5 Billion senior notes. Herzog

Herzog Fox & Neeman Acted as Israeli Counsel for a Consortium of Banks in a 4.5 Billion Debt Offering by Teva Pharmaceutical Industries Ltd.
We are delighted to invite you to an exciting Privacy Tech event we will hold on March 7th. The new

Privacy as an Opportunity | Herzog Fox & Neeman’s Tech & Regulation Event Save The Date 7.3.18
Herzog Fox & Neeman, together with FPI, is delighted to invite you to a morning session for private equity fund
Emphasising Energy and Infrastructure | Private Equity – Morning Session for Fund Investors | 05.03.18
Herzog Fox & Neeman, together with the London office of Shearman and Sterling, represented a consortium of local and international

Herzog Fox & Neeman Represented Both Local and International Lenders in a USD 1.250 Billion Financing to Energean Israel
Herzog is delighted to have been ranked Tier 1 in 6 practice areas in Chambers Global 2018: Banking & Finance

Herzog Fox & Neeman Leads Israeli Market in 2018 Chambers Global Rankings
We are pleased to introduce you to our February edition of the Technology & Regulation Client Update, which includes several
Client Update | Herzog Fox & Neeman Technology & Regulation
The Bank of Israel this week published Guidelines setting out the criteria to be satisfied by potential purchasers of the

Client Update | More Clarity on Who Will Be Allowed to Acquire Israel’s Credit Card Companies
Dear clients and friends, In Israel, health information is constantly being processed and recorded on a large scale, and due

Client Update | New Regulation on the Use of Health Data for Research and Commercial Purposes
Further to our circular of December 12, 2017 regarding the new Voluntary Disclosure Procedure of the Israeli Tax Authority (the


